BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 25595318)

  • 21. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
    Seuring T; Archangelidi O; Suhrcke M
    Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can higher spending on primary healthcare mitigate the impact of ageing and non-communicable diseases on health expenditure?
    Hou X; Liu L; Cain J
    BMJ Glob Health; 2022 Dec; 7(12):. PubMed ID: 36564087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative financing analysis and political economy of noncommunicable diseases.
    Jakovljevic M; Jakab M; Gerdtham U; McDaid D; Ogura S; Varavikova E; Merrick J; Adany R; Okunade A; Getzen TE
    J Med Econ; 2019 Aug; 22(8):722-727. PubMed ID: 30913928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on Noncommunicable Diseases (NCDs) burden, its socio-economic impact and the strategies for prevention and control of NCDs in India.
    Kundu MK; Hazra S; Pal D; Bhattacharya M
    Indian J Public Health; 2018; 62(4):302-304. PubMed ID: 30539894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consumption displacement in households with noncommunicable diseases in Bangladesh.
    Datta BK; Husain MJ; Fatehin S; Kostova D
    PLoS One; 2018; 13(12):e0208504. PubMed ID: 30543648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who is bearing the financial burden of non-communicable diseases in Mongolia?
    Dugee O; Palam E; Dorjsuren B; Mahal A
    J Glob Health; 2018 Jun; 8(1):010415. PubMed ID: 29564086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Global Burden of Disease 2020 Health Financing Collaborator Network
    Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2017 May; 389(10083):2005-2030. PubMed ID: 28433260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
    Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
    Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic burden of non-communicable diseases on households in Nigeria: evidence from the Nigeria living standard survey 2018-19.
    Odunyemi A; Rahman T; Alam K
    BMC Public Health; 2023 Aug; 23(1):1563. PubMed ID: 37592334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden and economic impact associated with non-communicable diseases among countries of World Health Organization South-East Asia Region - a systematic review protocol.
    Menon GR; Misra S; Deo V; Yadav J; Joshi P; Varghese C; John D
    JBI Evid Synth; 2024 Jun; ():. PubMed ID: 38832454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic effect of noncommunicable diseases on households and nations: a review of existing evidence.
    Engelgau M; Rosenhouse S; El-Saharty S; Mahal A
    J Health Commun; 2011 Aug; 16 Suppl 2():75-81. PubMed ID: 21916715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
    Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
    Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.